CPAP Therapy for Sleep Apnoea

Continuous positive airway pressure (CPAP) therapy for obstructive sleep apnoea, including titration sleep study, mask fitting, and follow-up support from the multidisciplinary Nuffield Sleep team.

Continuous positive airway pressure (CPAP) therapy remains the most effective treatment for moderate-to-severe obstructive sleep apnoea (OSA), the most prevalent sleep disorder characterised by repeated upper airway collapse during sleep. At Nuffield Sleep, CPAP therapy is initiated following confirmation of OSA through a diagnostic polysomnography study, with the optimal pressure determined during a CPAP titration night — either as a split-night study or a separate attended titration. The clinic's sleep team supports patients through the full CPAP journey: mask selection from the range of nasal pillow, nasal, and full-face interfaces to match the patient's anatomy and sleeping position; pressure calibration to achieve adequate control of apnoea events while maintaining patient comfort; and data download reviews at follow-up appointments to assess therapy adherence, residual AHI, mask leak, and usage hours per night. For patients who struggle to tolerate fixed CPAP pressure, auto-titrating (APAP) devices that self-adjust within a prescribed range may be recommended. Nuffield Sleep's multidisciplinary structure means that patients with positional OSA may be assessed for surgical alternatives (such as positional therapy devices or upper airway surgery by the ENT surgical team), and that CPAP-naive patients with anxiety around device use or claustrophobia can access the clinic's mental health practitioners for desensitisation support. Nutritional management of obesity-related OSA — a common exacerbating factor — is also integrated into the care plan.